What is the ROCE (Return on Capital Employed) of Precigen this year?
The ROCE of Precigen is -1.42 undefined this year.
Precigen ROCE 2025
Precigen ROCE
-1.42
Ticker
PGEN
ISIN
US74017N1054
WKN
A2PZG1
In 2025, Precigen's return on capital employed (ROCE) was -1.42, a 89.12% increase from the -0.75 ROCE in the previous year.
Precigen Aktienanalyse
What does Precigen do?
Precigen Inc is a biotechnology company headquartered in Germantown, Maryland, USA. The company was founded in 1991 under the name Human Genome Sciences Inc and became the first company in the industry to unlock genetic genes for drug development. In 2019, the company was renamed Precigen Inc. The company specializes in the development of cell and gene therapy products based on the latest advances in regenerative medicine. The goal is to treat diseases that have been difficult or even considered incurable through gene therapy, genome sequencing, and artificial intelligence. Precigen is divided into several divisions: Precigen ActoBio, Precigen Genome, Precigen RegenX, and Precigen Triple Gem. The divisions differ in product development and target application areas. Precigen ActoBio focuses on the development of biological therapies for autoimmune diseases. The company is working on an oral immunotherapy that can treat respiratory and inflammatory bowel diseases. The product is in the testing phase and if all goes well, approval could be within reach. Precigen Genome specializes in genome sequencing. The data from the genes is decoded to develop better medical diagnoses and therapies. Precigen Genome's services range from sequencing genomic information to uncovering further details to interpreting genome data. Precigen RegenX develops gene therapy products for the treatment of rare but severe genetic diseases. The aim is to modify specific genes in the body to achieve a cure or alleviate symptoms. An example of a product from Precigen RegenX is a gene therapy for hemophilia. This product is being tested in phase II clinical trials and could represent a true revolution in treatment. Precigen Triple Gem is the company's newest division, founded in 2020. It is a research and development project focused on novel cancer therapies. The main focus is on the development of CAR-T cells that can recognize and destroy various types of cancer cells. The company has already achieved promising results. The products from Precigen aim to simplify the treatment of severe diseases and minimize side effects through integration into molecular medicine. Patient safety is the top priority. To ensure this, strict testing phases are undergone and there is close monitoring of product development. Precigen's business strategy is based on collaboration with other companies and institutions. The company works with large pharmaceutical companies to support production, distribution, and marketing of the products, among other partnerships. Another important partnership is with universities and research institutions, which help the company in developing new technologies, improving production processes, and conducting clinical trials. This collaboration leads to faster research insights and a larger pool of knowledge and know-how. Precigen is also committed to recruiting the best talent and qualified personnel in the field of biotechnology. Overall, Precigen is an extremely innovative and promising company in the field of regenerative medicine and gene therapy. The company relies on a clever business strategy and forward-thinking partnerships to develop even better therapies for serious, previously incurable diseases in the future. Precigen ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Precigen's Return on Capital Employed (ROCE)
Precigen's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Precigen's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Precigen's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Precigen’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Precigen stock
How has the ROCE (Return on Capital Employed) of Precigen developed compared to the previous year?
The ROCE of Precigen has increased by 89.12% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Precigen?
A high Return on Capital Employed (ROCE) indicates that Precigen has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Precigen?
A low ROCE (Return on Capital Employed) can indicate that Precigen has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Precigen impact the company?
An increase in the ROCE of Precigen can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Precigen affect the company?
A decrease in ROCE of Precigen can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Precigen?
Some factors that can affect Precigen's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Precigen so important for investors?
The ROCE of Precigen is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Precigen take to improve the ROCE?
To improve the ROCE, Precigen can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Precigen pay?
Over the past 12 months, Precigen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Precigen is expected to pay a dividend of 0 USD.
What is the dividend yield of Precigen?
The current dividend yield of Precigen is .
When does Precigen pay dividends?
Precigen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Precigen?
Precigen paid dividends every year for the past 0 years.
What is the dividend of Precigen?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Precigen located?
Precigen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Precigen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Precigen from 10/8/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2025.
When did Precigen pay the last dividend?
The last dividend was paid out on 10/8/2025.
What was the dividend of Precigen in the year 2024?
In the year 2024, Precigen distributed 0 USD as dividends.
In which currency does Precigen pay out the dividend?
The dividends of Precigen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Precigen
Our stock analysis for Precigen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Precigen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
